You are here: Industry Insights > Roche

News List

Roche's marketing application for Tecentriq in small cell lung cancer gets FDA priority review firstwordpharma
December 05, 2018
Roche said Wednesday that the FDA granted priority review to a marketing application seeking approval of Tecentriq (atezolizumab), in combination with chemotherapy, for the initial treatment of people with extensive-stage small cell lung cancer (SCLC). Th
UCB, Roche lead new investments in UK's life sciences sector firstwordpharma
December 05, 2018
UCB will invest 1 billion pounds ($1.3 billion) in R&D in the UK over the next five years, including the construction of a new facility, as part of the UK Government's life sciences industrial strategy outlined on Wednesday.
UCB, Roche lead new investments in UK's life sciences sector firstwordpharma
December 05, 2018
UCB will invest 1 billion pounds ($1.3 billion) in R&D in the UK over the next five years, including the construction of a new facility, as part of the UK Government's life sciences industrial strategy outlined on Wednesday.
Roche Expands Access to the Diabetes Management Solution mySugr in the US and Canada pharmafocusasia
December 03, 2018
Roche today announced the signing of a partnership agreement and investment in Care Innovations, a leading provider of telemedicine services to patients suffering from chronic conditions Illnesses that connect remotely with their care teams.
Roche subsidiary Genentech to acquire Jecure Therapeutics pharmaceutical-technology
November 30, 2018
Swiss firm Roche Group’s affiliate Genentech has agreed to acquire US biotechnology company Jecure Therapeutics to strengthen its position in the treatment of liver diseases.....
Trump Medicare Plan Targets Drugs From AstraZeneca to Roche firstwordpharma
November 28, 2018
A proposal from the US Centers for Medicare and Medicaid Services (CMS) could have negative consequences for a wide range of drugmakers, Bloomberg reported Tuesday.
Roche inks deal to purchase Jecure Therapeutics firstwordpharma
November 28, 2018
Roche's Genentech unit has entered into a definitive agreement to acquire Jecure Therapeutics, obtaining full rights to the latter’s entire preclinical portfolio of NLRP3 inhibitors, Jecure announced Tuesday. Financial terms of the deal were not divulged.
Roche pulls extended use application for kidney cancer drug pharmaphorum
November 26, 2018
Roche has withdrawn an application to the European Medicines Agency (EMA) for an expanded use for its immunotherapy drug, Tecentriq....
Ascletis and Roche enter exclusive Pegasys partnership in China for viral Hepatitis pharmafocusasia
November 26, 2018
hanghai Roche Pharmaceuticals Ltd. (Roche) and Ascletis BioScience Co., Ltd. (Ascletis, listed parent company stock code 1672.HK) jointly announce that....
Roche yanks Tecentriq kidney cancer apps in U.S., EU fiercepharma
November 22, 2018
Roche’s immuno-oncology rivals are hurtling toward a showdown in previously untreated kidney cancer. But the Swiss drugmaker has decided to pull its horse out of the race.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page